SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Feb-21 5:18 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 02-Feb-21 | Grant | 9,700 | -- | -- | 22% 44.92K to 54.63K | |
26-Jan-21 6:32 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 23-Jan-21 | Payment of Exercise | 1,892 | $47.70 | $90,248.40 | (4%) 46.82K to 44.92K | (2%) |
11-Jan-21 8:05 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 07-Jan-21 | Payment of Exercise | 906 | $50.97 | $46,178.80 | (2%) 47.72K to 46.82K | 3% |
07-Jan-21 4:30 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 05-Jan-21 | Payment of Exercise | 2,088 | $50.02 | $104,442.00 | (4%) 49.81K to 47.72K | 0% |
27-Jan-20 4:15 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 23-Jan-20 | Payment of Exercise | 1,793 | $57.98 | $103,958.00 | (3%) 51.6K to 49.81K | |
07-Jan-20 6:25 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 07-Jan-20 | Payment of Exercise | 904 | $57.38 | $51,871.50 | (2%) 52.51K to 51.6K | |
07-Jan-20 6:25 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 05-Jan-20 | Grant | 21,500 | -- | -- | 69% 31.01K to 52.51K | |
25-Jan-19 8:05 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 23-Jan-19 | Grant | 20,900 | -- | -- | 207% 10.11K to 31.01K | |
25-Jan-19 8:05 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 07-Jan-19 | Payment of Exercise | 858 | $41.33 | $35,461.10 | (8%) 10.97K to 10.11K | (1%) |
09-Jan-18 5:48 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 07-Jan-18 | Grant | 10,000 | -- | -- | 1035% 0.97K to 10.97K | |
19-May-17 4:42 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 19-May-17 | Market Purchase | 255 | $79.69 | $20,321.00 | 36% 0.71K to 0.97K | (47%) |
16-May-17 5:37 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 16-May-17 | Market Purchase | 200 | $82.24 | $16,448.00 | 39% 0.51K to 0.71K | (49%) |
21-Mar-17 4:37 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 21-Mar-17 | Market Purchase | 61 | $83.98 | $5,122.78 | 14% 0.45K to 0.51K | (50%) |
10-Mar-17 7:20 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 09-Mar-17 | Market Purchase | 450 | $77.84 | $35,028.50 | 100% 0 to 0.45K | (46%) |
02-Dec-16 11:40 AM View: | Isolagen Inc. (FCSC) | 02-Dec-16 | Market Purchase | 50,000 | $0.92 | $46,085.00 | 90% 55.6K to 105.6K | (89%) |
13-Nov-15 4:36 PM View: | Isolagen Inc. (FCSC) | 13-Nov-15 | Market Purchase | 3,000 | $5.00 | $14,997.00 | 6% 52.6K to 55.6K | (98%) |
11-Aug-15 4:01 PM View: | Isolagen Inc. (FCSC) | 11-Aug-15 | Market Purchase | 3,500 | $6.54 | $22,890.00 | 7% 49.1K to 52.6K | (98%) |
13-May-15 4:15 PM View: | Isolagen Inc. (FCSC) | 13-May-15 | Market Purchase | 16,600 | $4.30 | $71,347.40 | 51% 32.5K to 49.1K | (98%) |
15-Dec-14 4:10 PM View: | Isolagen Inc. (FCSC) | 12-Dec-14 | Market Purchase | 5,000 | $2.52 | $12,600.00 | 18% 27.5K to 32.5K | (96%) |
21-Nov-14 4:04 PM View: | Isolagen Inc. (FCSC) | 20-Nov-14 | Market Purchase | 5,000 | $2.54 | $12,685.50 | 22% 22.5K to 27.5K | (96%) |
06-Jun-14 9:21 AM View: | Isolagen Inc. (FCSC) | 05-Jun-14 | Market Purchase | 12,500 | $2.95 | $36,925.00 | 125% 10.0K to 22.5K | (97%) |
21-Nov-13 4:40 PM View: | Isolagen Inc. (FCSC) | 21-Nov-13 | Market Purchase | 10,000 | $3.69 | $36,900.00 | 100% 0 to 10.0K | (97%) |